Skip to main content

Table 3 Direct medical costs and proportion of patient’s co-payment for prostate cancer in Korea from 2005 to 2014

From: National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database

Characteristic 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
1 yr. before 2956 (27.8) 3307 (23.0) 3532 (22.0) 3793 (22.2) 3854 (22.3) 4020 (21.0) 4206 (20.4) 4183 (20.2) 4058 (20.1) 4141 (19.7)
1st yr 9077 (16.1) 9890 (13.7) 10,088 (16.7) 10,448 (24.0) 10,752 (24.6) 11,025 (23.6) 11,568 (22.9) 11,305 (22.0) 11,299 (22.0) 11,741 (22.1)
2nd yr 6220 (13.9) 6086 (14.6) 5897 (15.1) 5802 (13.7) 5831 (12.7) 5944 (12.1) 5563 (12.8) 5544 (12.9) 5793 (12.4)  
3rd yr 5711 (14.9) 5862 (15.2) 5534 (14.3) 5650 (13.0) 5521 (12.9) 5178 (13.4) 5191 (13.4) 5393 (13.3)   
4th yr 5473 (15.7) 5534 (14.3) 5261 (13.5) 5273 (13.4) 4985 (13.7) 5023 (13.9) 5152 (13.8)    
5th yr 5491 (14.5) 5529 (13.8) 5098 (13.7) 5034 (14.2) 4970 (14.1) 5140 (14.3)     
6th yr 5437 (14.8) 5211 (15.2) 4767 (15.6) 4603 (16.5) 4900 (15.7)      
7th yr 5324 (14.8) 5070 (15.2) 4800 (16.0) 4816 (16.2)       
8th yr 4952 (16.1) 4847 (15.8) 4912 (15.9)        
9th yr 4959 (16.4) 5057 (15.9)         
10th yr 5079 (16.4)          
  1. Average annual payments from 1 yr. prior to primary treatment to 10th yr. thereafter (1000 KRW); KRW Korean won